24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial

Clinical trial NCT04989257 · UNKNOWN

Trial details

NCT number: NCT04989257
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

High Ischemic Risk

Start date: 2021-08-01
Primary completion: 2026-06-01
Enrollment: 3488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.